Fiche personne
Coordonnées
Centre Georges-François Leclerc
1 rue du Professeur Marion
BP 77980
21079 DIJON
03 80 73 75 38
Territoire
Bourgogne
Statut
Interne
Affiliation
Équipes/plateformes
Plateforme Plateforme de transfert en biologie cancérologique
Projets
Evaluation of a Vaccine Associating NEo-antigens and adjuvant to SENsitize Tumors resistant to IMmunotherapy: a Proof of concept (EVANeSenT ImP)
2022 - Porteur du projet : Dr BELLIO Hélène
Publications
Intracranial response of brain metastases in patients with HER2-amplified breast cancer treated with trastuzumab-deruxtecan after failure of tucatinib-based therapy.
Desmoulins I, Bellio H, Méjean N, Truntzer C, Ladoire S
Eur J Cancer. 2023 05 9;187:161-163
[New drug approval: Nivolumab for adjuvant treatment of patients with PD-L1-positive (≥1%), muscle invasive urothelial carcinoma who are at high risk of recurrence after radical resection].
Bellio H, Benderra MA
Bull Cancer. 2022 08 19;:
Small Cell Neuroendocrine Carcinoma of the Paranasal Sinuses with Unexpected Location and Clinical Presentation and Occupational Exposure: A Case Report.
Tankere P, Zanetta S, Kaderbhai CG, Bellio H, Lagrange A, Garcier M, Ghiringhelli F
Am J Case Rep. 2022 Mar 2;23:e934980
